Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide (VOD-DF)
Prospective Randomized Study of the Incidence and Outcome of Veno-Occlusive Disease (VOD) With the Prophylactic Use of Defibrotide (DF) in Pediatric Stem Cell Transplantation
Sponsor: Deutsche Krebshilfe e.V., Bonn (Germany)
Listed as NCT00272948, this PHASE2/PHASE3 trial focuses on Hepatic Veno-Occlusive Disease and remains completed. Sponsored by Deutsche Krebshilfe e.V., Bonn (Germany), it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Nov 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Dec 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsche Krebshilfe e.V., Bonn (Germany)
- European Society for Blood and Marrow Transplantation
- Jazz Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Basel, Switzerland , Bern, Switzerland , Dresden, Germany , Dublin, Ireland , Düsseldorf, Germany , Frankfurt, Germany , Geneva, Switzerland , Genova, Italy , Gothenburg, Sweden , Graz, Austria and 20 more locations